Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Dyspnea

• 129Xe MRI Cardiopulmonary
• Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
• Efficacy of L-menthol on Breathlessness in Chronic Obstructive Pulmonary Disease
• The Effect of Nebulized Epinephrine in Asthma Exacerbation in Pediatric Age Group With the Standard Treatment Compared to Standard Treatment With Placebo Using Improvement PRAM Score as a Primary Outcome
• Muscle Reflex in Hypoxia
• Improving Quality of Life and Daily Life Activities With Bioarginine in Patients With COPD: a Multicenter, Randomized, Controlled, Proof of Concept Study
• AVICOVID-3 Inhaled Use of Zyesami for Treatment of Severe COVID-19
• Post-Acute Sequelae of Coronavirus-19 (COVID-19) With Dyspnea on Exertion And Associated TaChycardia TrEatment Study
• Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD
• Inhaled Nitric Oxide (iNO) in Post-Pulmonary Embolism (Post-PE)
• Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN)
• Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Cancer Patients
• Clevidipine vs Placebo or Standard of Care for Dyspnea and Blood Pressure Control in AHF
• Morphine for Dyspnea in Pulmonary Fibrosis
• Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19
• Low Dose Morphine to Relieve Dyspnea in Acute Respiratory Failure (OPIDYS)
• Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection
• Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients
• Mechanisms for Dyspnea on Exertion in Children With Obesity and Asthma: Distinct Physiological Phenotypes
• The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease.
• Effect of Sublingual Fentanyl on Breathlessness in COPD
• Morphine or Fentanyl for Refractory Dyspnea in COPD
• Morphine to Maximize the Benefits of Exercise Training in COPD or ILD and Persistent Breathlessness
• The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in COPD
• The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
• Differential Mechanisms of Dyspnea Relief in Advanced COPD: Opiates vs. Bronchodilators
• Effect of Morphine on Dyspnea and 6-Minute Walk Distance in Pulmonary Arterial Hypertension
• Dexamethasone in Controlling Dyspnea in Patients With Cancer
• Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial
• Nebulized Fentanyl in Patients With Mild to Moderate Interstitial Lung Disease and Chronic Dyspnea
• Specificity of Dyspnoea Relief With Inhaled Furosemide
• Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients
• Validation of an Observational Scale of Dyspnea in Non-communicating Patients in the ICU
• Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension
• Breathlessness Exertion and Morphine Sulphate
• Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease
• Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea
• Ultibro® Versus Spiriva® Alone to Reduce Exertional Dyspnea in Patients With Moderate to Severe COPD
• Aerosol Inhalation Treatment for Dyspnea - Patients
• Opioids for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease
• The Use of Intranasal Fentanyl for the Treatment of Incident Dyspnea in Congestive Heart Failure: A Prospective Trial
• Morphine for Treatment of Dyspnea in Patients With COPD
• Evaluation of Transient Dyspnea During Gadoxetic Acid Enhanced Multiphasic Liver MRI
• Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor
• Effect of Tiotropium Inhalation Capsules on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary Rehabilitation
• 12-week Treatment With Inhaled Tiotropium (18 mcg Once Daily) on Lung Function and Static Lung Volumes in Stable, Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. Correlation to Dyspnoea Scales
• Understanding the Importance of Plasticity in the Brain Mechanisms of Dyspnoea Perception
• Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer
• Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea
• Inhaled Fentanyl Citrate & Dyspnea
• Inhaled Ondansetron & Dyspnea
• Inhaled Nebulized Furosemide & Physical Activity-Related Breathlessness
• Effect of Desmopressin on Platelet Function in CKD Patients on Antiplatelet Drug
• Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea
• Morphine, Dyspnea, Exercise and COPD
• Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients
• Dexamethasone Dyspnea Study
• Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease
• Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure
• The Role of Substance P on Perception of Breathlessness During Resistive Load Breathing
• Non Opioid Treatment for Experimental Dyspnea
• Breakthrough Dyspnea Fentanyl Study in Cancer Patients
• The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
• Aerosol Inhalation Treatment for Dyspnea
• Effect of Ketoconazole on Breathlessness
• Effect of Indacaterol Maleate in Chronic Obstructive Pulmonary Disease (COPD) on Lung Volume and Related Dyspnea
• The Impact of Udenafil on Exercise Capacity in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients
• Ranolazine in Ischemic Cardiomyopathy
• Extended Drug Utilization Study Among Patients Exposed to Ticagrelor, Clopidogrel and Prasugrel
• Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics
• Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer
• Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study
• Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan
• Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease
• Palliation of Dyspnea in Advanced Chronic Obstructive Pulmonary Disease (COPD)
• Effect of Inhaled Fentanyl on Dyspnea and Exercise Tolerance in Chronic Obstructive Pulmonary Disease (COPD)
• Effectiveness of Inhaled Corticosteroids in Preschool Children With Acute Dyspnea and Wheeze
• Role of Endorphins in Perception of Dyspnea With Resistive Loading in Chronic Obstructive Pulmonary Disease (COPD)
• Evaluation of Breathing Pattern and Dyspnea in Subjects With Tetraplegia
• Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer
• Heliox in Experimental Upper Airway Obstruction
• An Exploratory Study, to Assess the Effect of Repeat-dose Inhaled Indacaterol Maleate (300 μg) on Dynamic and Static Lung Hyperinflation, Subjective Breathlessness and Health Status in Patients With Chronic Obstructive Pulmonary Disease(COPD)
• Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients
• Double Blind Randomized Placebo Controlled Trial of Natrecor in Acute Decompensated Heart Failure With Normal EF
• Role of Endorphins in the Perception of Dyspnea in Patients With Chronic Obstructive Pulmonary Disease
• Shortness Of Breath Questionnaire Validation Study
• "Red Morphine Drops" for Symptomatic Treatment of Dyspnoea in Lung Cancer
• Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)
• A Study of Short-Term Outcomes and Economic Impact For Patients With Worsening Congestive Heart Failure When Natrecor (Nesiritide) is Added to Standard-Care Therapy, Compared to Administration of Placebo With Standard-Care Therapy
• Buspirone in Reducing Shortness of Breath in Patients With Cancer
• The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart Failure